Drug intelligence / Profile preview

ProtegeRX

Development stage
Unknown
Lead developer
Medtronic
Modality
Small Molecules
Administration
Oral
01

Overview

ProtegeRX is a prescription-strength prenatal multivitamin and mineral supplement designed to provide comprehensive nutritional support for women during pregnancy and the postnatal period. Developed by Method Pharmaceuticals, it is specifically formulated to meet the increased metabolic and nutritional requirements of both the mother and the developing fetus. The supplement contains a blend of essential vitamins and minerals, including L-methylfolate, which is the bioactive form of folic acid that supports neural tube development and DNA synthesis, particularly in individuals with MTHFR gene variations. Additionally, it provides iron to support the expansion of maternal blood volume and prevent iron-deficiency anemia, along with other key nutrients like Vitamin D3, B-complex vitamins, and zinc to promote overall fetal growth and maternal well-being.

Brand names
ProtegeRX
Other names
Protege RXProtegeRX Prenatal
02

Targets

FOLR1 (FRα)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on ProtegeRX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProtegeRX.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call